Tag: Drug Development

BIOCAD’s first biosimilar of interferon beta-1a approved in Russia

biocad
The Ministry of Health (MoH) of the Russian Federation has awarded Biocad marketing authorization for its interferon beta-1a biosimilar, a knockoff of Biogen's Rebif® that is a key component in treatm...

Exelixis and Bristol-Myers Squibb announced the collaboration

bms
Exelixis, Inc. and Bristol-Myers Squibb Company announced the companies have entered into a clinical development collaboration to evaluate CABOMETYX™ (cabozantinib), Exelixis’ small molecule inhibitor...

Russia has established technological platforms for development of advanced biologics

skvotsova
In her interview to NTV reporter at the Investment Forum in Sochi, Russian Minister of Health has told about the most advanced pharmaceuticals aimed at treatment of yet incurable diseases that are bei...

Russian and Swedish scientists are developing an anti-ageing drug

drugs
According to a new research, the experiments on mice that were undertaken by a group of Swedish and Russian scientists have proved to be a breakthrough in the field of struggling against ageing. The r...

Merck antiviral medicine prevents serious infection after marrow transplant

merck
Merck & Co., known as MSD, announced results of the pivotal Phase 3 clinical study of letermovir, an investigational antiviral medicine for the prevention of clinically-significant cytomegalovirus...

Sanofi and Lonza will build new $285 million biologics facility

sanofi
French drugmaker Sanofi and Swiss manufacturer Lonza will invest 270 million euros ($285 million) in a new large-scale biologics facility that will produce monoclonal antibodies by 2020. Pending re...

Yaroslavl pharmaceutical cluster will start training straight at school

yaroslavl
Next academic year Yaroslavl pharmaceutical cluster will begin educating its experts at the secondary school level as a starting point. A pharmaceutical class will be organized at Yaroslavl lyceum №86...

Anti-HIV drugs development with the use of supercomputers is underway in Belarus

research
By means of computer modelling Belarusian scientists have identified chemical compounds that are potentially prospective for development of new HIV drugs. Alexander Andrianov, Head of the Project, Chi...

New antimicrobial agents were patented in Russia

microbe
Researchers of Perm University have developed new chemicals that are active against staphylococcus – the causative agent of hospital-acquired infections. In February, University chemists filed a paten...

Saneca will drive R&D Initiative following €1.5 million funding

saneca
Contract development and manufacturing organization (CDMO) Saneca Pharma is driving forward with new research and development initiatives for the manufacture of active pharmaceutical ingredients (...

Russian and Indian universities will help to develop affordable medicines

drug-development
Stavropol State Medical University, Delhi Pharmaceutical Sciences and Research University and the Chennai International Centre for Medical Education and Research (ICMER) have launched a tie-up program...

Iodonium salts production technology will reduce the cost of drug manufacturing

iodonium salts
Scientists of the Tomsk Polytechnic University (TPU) together with foreign colleagues have developed eco-friendly iodonium salts production technology, which will reduce the cost of manufacturing of m...

Ferring and Enteris BioPharma entered License Agreement

ferring
Ferring Pharmaceuticals and Enteris BioPharma, Inc. announced that the companies have entered into a license agreement and initiated an early development agreement to leverage Enteris’ proprietary...

Bioluminescent proteins enhance efficiency of new medicines testing

The scientists of Biophysics Institute at Krasnoyarsk Scientific Center (Federal Research Center Scientific Center of the RAS Siberian Branch) have produced bioluminescent proteins to be used for test...

Microgen is ready to market a unique bacteriophage

Combined bacteriophage preparation "Enterobacter multivalent purified" intended for treatment and prevention of infections caused by Enterobacter species has successfully passed the phase II clinical ...

Updated version of Immune Response Template will be released by ISBM

Institute for Systems Biology Moscow (ISBM) announced the recent update of the Immune Response Template (IRT) platform and its online demo. The project aimed to integrate and visualize available data ...